Results 41 to 50 of about 6,503 (137)

Novel approaches for drug development against chronic primary pain: A systematic review

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus   +5 more
wiley   +1 more source

Case Report Of Cryoneurolysis For The Treatment Of Refractory Intercostobrachial Neuralgia With Postherpetic Neuralgia

open access: yesLocal and Regional Anesthesia, 2019
Garret Weber, Kenneth Saad, Motaz Awad, Tiffany H Wong Department of Anesthesiology, New York Medical College, Valhalla, NY, USACorrespondence: Garret WeberDepartment of Anesthesiology, New York Medical College, Westchester Medical Center, 100 Woods Road,
Weber G, Saad K, Awad M, Wong TH
doaj  

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain? [PDF]

open access: yes, 2013
An expert group of 40 pain specialists from 16 countries performed a first assessment of the value of predictors for treatment success with 5% lidocaine-medicated plaster in the management of cancer pain with neuropathic components and trigeminal ...
Brasseur, L   +3 more
core   +1 more source

The Role of Viruses in the Pathogenesis of Periodontitis

open access: yesJournal of Periodontal Research, EarlyView.
This narrative review aimed to summarize current evidence on the presence and potential pathogenic role of viruses in periodontitis. Design: Narrative Review; Population: Patients with periodontitis; Exposure: Detection of viruses in oral samples (biopsies, saliva, gingival crevicular fluid, subgingival plaque, blood); Outcome: Viral prevalence, load ...
Kim Natalie Stolte   +2 more
wiley   +1 more source

Communication gaps between physicians and patients with postherpetic neuralgia: results from a national study on practice patterns

open access: yesJournal of Pain Research, 2011
Terry A Glauser1, Gregory D Salinas1, Holder Nevins1, J Chad Williamson1, Mark S Wallace2, Maziar Abdolrasulnia11CE Outcomes, Birmingham, AL, 2Department of Anesthesiology, University of California San Diego School of Medicine, La Jolla, CA ...
Glauser TA   +5 more
doaj  

What is the prognosis of postherpetic neuralgia? [PDF]

open access: yes, 2003
Postherpetic neuralgia occurs rarely among patients aged 70 years, 25% had some pain at 3 months, but only 10% had pain at 1 year, and none had severe pain.
Gazewood, John D., Meadows, Susan E.
core  

Genitofemoral neuralgia : adding to the burden of chronic vulvar pain [PDF]

open access: yes, 2015
The vulva is a particularly common locus of chronic pain with neuropathic characteristics that occurs in women of any age, though most women with neuropathic type chronic vulvar pain will remain undiagnosed even following multiple physician visits. Here,
De Muynck, Martine   +2 more
core   +2 more sources

Postherpetic Zoster Neuralgia

open access: yesДетские инфекции (Москва), 2016
The article is devoted postzoster neuralgia, which presents a literature review and clinical case own observations — unfavorable outcome of varicella in a child of 7 years in the form of formed postzoster ganglionitis facial and trigeminal nerve - Hunt ...
F. S. Кharlamova   +5 more
doaj   +1 more source

Systematic review and meta-analysis of genetic risk factors for neuropathic pain [PDF]

open access: yes, 2018
Neuropathic pain (NP) is an increasingly common chronic pain state and a major health burden, affecting approximately 7-10% of the general population. Emerging evidence suggests that genetic factors could partially explain individual susceptibility to NP
Hébert, Harry L.   +4 more
core   +2 more sources

Valproic acid for treatment of traumatic brain injury: Study protocol for the VIBRANT prospective randomized trial

open access: yesTransfusion, EarlyView.
Abstract Background Traumatic brain injury (TBI) carries significant mortality and morbidity in civilian and military populations. Current treatment guidelines for TBI are primarily supportive, and no pharmacological agent exists to attenuate the progression of brain injury.
Maxime A. Visa   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy